Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses  by McCormick, A.Louise et al.
Differential function and expression of the viral inhibitor of caspase
8-induced apoptosis (vICA) and the viral mitochondria-localized
inhibitor of apoptosis (vMIA) cell death suppressors conserved in
primate and rodent cytomegaloviruses
A. Louise McCormick,a,1 Anna Skaletskaya,b,1 Peter A. Barry,c
Edward S. Mocarski,a and Victor S. Goldmacherb,*
a Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
b ImmunoGen, Inc., Cambridge, MA 02139, USA
c Center for Comparative Medicine, University of California, Davis, CA 95616, USA
Received 1 April 2003; returned to author for revision 23 May 2003; accepted 21 July 2003
Abstract
Human cytomegalovirus (CMV) genes UL36 and UL37 encode viral inhibitor of caspase-8-induced apoptosis (vICA) and viral
mitochondria inhibitor of apoptosis (vMIA), respectively. Rhesus macaque CMV homologues, denoted Rh-vICA and Rh-vMIA, were
identified and found to suppress apoptosis. One of these functions was conserved in MCMV, encoded by the M36 gene and denoted
M-vICA. Conserved regions were compared to domains important to vICA- and vMIA-mediated cell death suppression. The conserved
sequences of primate CMV vMIA homologues overlapped with the two known functional domains, providing further evidence supporting
a crucial role of vMIA in cell death suppression. RNA blot analyses revealed that expression of murine and rhesus macaque CMV UL36
and UL37 homologues started early and continued through late times of infection. Murine CMV homologues were expressed with 
(immediate early) kinetics, like human CMV UL36 and UL37, whereas rhesus macaque CMV homologues exhibited  (delayed early)
kinetics. Despite differences in organization and transcriptional regulation, this region appears to carry out a conserved role in cell death
suppression. When viewed in light of sequence conservation, a functional vMIA homologue appears to be encoded by every primate CMV,
whereas a functional vICA homologue appears to be encoded by all cytomegaloviruses for which sequence data are available.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Cell death by apoptosis is an evolutionarily conserved
process that eliminates cells during development or differ-
entiation as well as a primitive host defense mechanism that
eliminates cells infected by viruses and other intracellular
pathogens (Roulston et al., 1999). Apoptosis can be induced
by intrinsic or extrinsic signals. Intrinsic signals may result
from viral infection and include stress, cell cycle arrest,
cytoplasmic calcium perturbation, and DNA damage. Ex-
trinsic signals arise as a result of the host immune response
through tumor necrosis factor-I (TNF-I) receptor, or Fas
activation (Wallach et al., 1999), or via delivery of proteases
by cytotoxic lymphocytes (Smyth et al., 2001). Once in-
duced, apoptosis may eliminate infected cells prior to re-
lease of viral progeny (Roulston et al., 1999).
Herpesviruses and other large DNA viruses have evolved
elaborate countermeasures to interfere with apoptosis in
order to maintain cell viability and escape immune clear-
ance (Alcami and Koszinowski, 2000; Boya et al., 2001;
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Tortorella et al., 2000; Tschopp et al., 1998a; White, 2001).
Human cytomegalovirus (HCMV) encodes two well-char-
acterized  (immediate early) proteins with potent antiapop-
totic activities (Goldmacher, 2002; Mocarski, 2002), viral
inhibitor of caspase-8-induced apoptosis (vICA), and viral
mitochondria-localized inhibitor of apoptosis (vMIA).
vICA prevents death receptor-induced apoptosis by binding
to and blocking activation of procaspase-8 (Skaletskaya et
al., 2001) in a manner analogous to cellular or viral Fas-
associated death domain-like IL-1-converting enzyme
(FLICE; an alternative name for caspase-8) inhibitory pro-
teins (FLIPs) (Roulston et al., 1999; Tortorella et al., 2000;
Tschopp et al., 1998b). HCMV vICA carries out this func-
tion despite the lack of a death effector domain or other
sequence homology with FLIPs. HCMV-encoded vMIA
blocks cytochrome c release and activation of downstream
effector caspases (Goldmacher, 2002; Goldmacher et al.,
1999) in a manner analogous to Bcl-2 homologues (Boya et
al., 2001) and adenovirus E1B19k (White, 2001). Like
Bcl-2, vMIA localizes to mitochondria and inhibits mito-
chondrial permeabilization induced by apoptotic signals.
vMIA, however, does not share any homology with Bcl-2
family members and, specifically, lacks Bcl-2 homology
domains BH1, BH2, BH3, or BH4. vMIA disrupts the
reticular structure of mitochondrial networks (McCormick
et al., 2003) through modulation of normal fission or fusion
processes. Additional HCMV gene products, including IE1
and IE2 (Zhu et al., 1995), as well as the murine CMV
(MCMV) UL45 homologue (Brune et al., 2001) may influ-
ence cell susceptibility to apoptosis but the nature of their
involvement remains to be elucidated (Castillo and Kow-
alik, 2002; Mocarski, 2002). In analyses thus far, HCMV
UL45 does not appear to show the same essential role as
MCMV M45 (Hahn et al., 2002).
Several lines of evidence (Skaletskaya et al., 2001; Gold-
macher et al., 1999) suggest that vICA and vMIA, together,
are critical for suppressing cell death during infection: (1)
Expression of vICA renders cells resistant to Fas-induced
apoptosis early in the infection cycle. (2) In the absence of
vICA, resistance begins later and coincides with the local-
ization of vMIA to mitochondria. (3) HCMV mutants lack-
ing both vMIA and vICA induce apoptosis during infection
of human fibroblasts and replicate poorly unless cells ec-
topically express either vMIA or an antiapoptotic Bcl-2
homologue (G. Hahn, personal communication). UL36 is
dispensable for replication in fibroblasts (Patterson and
Shenk, 1999), and commonly used laboratory strains of
virus accumulate inactivating mutations in this gene (Ska-
letskaya et al., 2001). It remains to be determined whether
UL36 is dispensable for replication of HCMV in other types
of permissive cells or in vivo, but in any case, it is likely that
the antiapoptotic function of vICA/UL36 provides a sur-
vival advantage for HCMV during natural infection.
All betaherpesviruses characterized to date carry se-
quence homologues of UL36 and UL37. MCMV (Rawlin-
son et al., 1996), rat CMV (RCMV) (Vink et al., 2000),
African green monkey CMV (AgmCMV) (Martin, 1999),
rhesus macaque CMV (RhCMV), described here and by
Hansen et al. (2003), chimpanzee CMV (ChCMV) (Davison
et al., 2003), human herpesvirus (HHV)6A (Gompels et al.,
1995), HHV6B (Dominguez et al., 1999), HHV7 (Nicholas,
1996), and herpesvirus tupaia (Bahr and Darai, 2001) each
encode homologues of HCMV UL36 (Chee et al., 1990).
Only primate CMVs retain an ORF with homology to UL37
exon 1 (UL37x1); other betaherpesviruses and rodent CMVs
lack this ORF. In HCMV, the 163-amino-acid segment
encoded by UL37x1 comprising vMIA is expressed as a
separate gene product and as a part of two additional UL37
gene products that arise by differential mRNA polyadenyl-
ation and splicing (Colberg-Poley, 1996). vMIA contains
two critical domains that are necessary and, together, suf-
ficient for blocking apoptosis (Goldmacher, 2002). gpUL37
and gpUL37M retain both of these domains and are anti-
apoptotic (Goldmacher, 2002; Goldmacher et al., 1999). In
contrast, all betaherpesviruses contain a homologue of the
UL37 exon 3 region that lies downstream from UL37x1
encoding the vMIA domain (Goldmacher, 2002). The UL37
exon 3 region likely carries out additional functions (Haya-
jneh et al., 2001b) which may be conserved in other beta-
herpesviruses, including those that lack obvious sequence
homology with vMIA.
Fig. 1. Comparison of proteins encoded by UL36 and UL37 homologues.
(A and B) Similarity of vICA (A) and vMIA (B) homologues displayed as
a dendrogram formed by a ClustalW pairwise alignment. Similarity scores
are indicated as a percentage (or a range) between pairs of sequences. (C
and D) Multiple pairwise alignments generated using ITERALIGN for
vMIA homologues (C) and vICA homologues (D). Red lines above the
sequence denote similarity blocks. Identical amino acids are dark shaded
and similar amino acids are light shaded. Blue lines below the sequences
denote regions of conserved motifs: vMIA domains A and B important for
targeting and antiapoptotic function (C) and vICA US22 family motifs
I–IV (D). In (D) asterisks denote amino acids or regions that are likely to
destroy function in variants of HCMV strains AD169varATCC (Cys131) or
TownevarRIT (Leu156 to His295), and the symbol  after Ile346 of Agm-
vICA denotes the limit of sequence information available.
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In order to determine whether homologues of UL36 and
UL37 of animal CMVs encode functional cell death sup-
pressors, we used sequence comparisons to identify poten-
tial functional domains and then evaluated a rodent
(MCMV) and a nonhuman primate (RhCMV) viral homo-
logue for cell death suppression activity.
Results
Identification of vICA and vMIA homologues in RhCMV
and AgmCMV
A genomic clone containing a region similar to HCMV
UL35 through UL38 was prepared from a well-character-
ized, pathogenic strain of RhCMV, 68-1 (Chang et al.,
2002; Lockridge et al., 1999; Sequar et al., 2002). Sequence
analysis (GenBank Accession AY158022) showed UL35,
UL36, UL37, and UL38 homologues organized in a colinear
fashion to HCMV (Chee et al., 1990; Tenney and Colberg-
Poley, 1991). A similar set of ORFs was also identified in
the genome of ChCMV (GenBank Accession AF480884;
Davison et al., 2003) and where sequence was available, for
AgmCMV (GenBank Accession U27649 and AF065657).
The four primate CMVs retained homologues of antiapop-
totic functions vICA, encoded by UL36, and vMIA, en-
coded by UL37x1. A thymidine insertion was found to
prematurely terminate the pUL36 homologue of RhCMV
relative to other homologues as well as compared to another
clone from this virus strain (Hansen et al., 2003). Based on
this information the insertion was corrected prior to further
analysis.
Next, we evaluated the level of sequence divergence of
vMIA/pUL37x1 and vICA/pUL36 homologues in primate
CMVs as well as in several other betaherpesviruses (Figs.
1A and B). Pairwise alignments suggested that pUL36 ho-
mologues in four primate viruses formed one close-similar-
ity branch that could be further subdivided into pairs: (1)
human and ChCMV and (2) rhesus macaque and Agm-
CMV. The two rodent CMV proteins (pM36 and pR36)
together with herpesvirus tupaia pT36 formed a second
branch that was more closely related to primate CMVs than
to other betaherpesviruses. HHV6A (pU17-16HHV6) and
HHV7 (pU17-16HHV7) constituted a distinct third branch.
These relationships reflected the previous estimated relat-
edness of these herpesviruses established using phyloge-
netic analyses of other ORFs (Hannenhalli et al., 1995;
Karlin et al., 1994; McGeoch et al., 1995, 2000). In the case
of primate pUL36 homologues, a high level of sequence
similarity suggested conservation of antiapoptotic function;
however, divergence of pUL36 homologues in rodent
CMVs and other betaherpesviruses raised a question of
whether these gene products would act as cell death sup-
pressors.
Analysis of vMIA/pUL37x1 homologues encoded by
primate viruses revealed a level of sequence similarity that
was comparable to that of pUL36 homologues. This evalu-
ation was limited to the primate CMVs due to the absence
of a UL37x1 region in other betaherpesviruses. Again, two
similarity branches were found, grouping HCMV with
ChCMV, and RhCMV and AgmCMV. The extent of se-
quence conservation in pRh37x1 and pAgm37x1 (65%) was
similar to that in the vICA homologues from these viruses
(66%). In contrast, vMIA was less similar to the ChCMV
homologue pCh37x1 (48%) than vICA was to pCh36
(74%). The similarity of the biology of HCMV and ChCMV
has been established (Perot et al., 1992; Swinkels et al.,
1984). In this work fibroblasts from either species were
found to support the growth of either CMV. The conserved
sequences between vMIA and pCh37x1 may be expected to
correspond to regions essential for cell death suppression
and viral replication.
vMIA homologues
We employed an alignment program (Brocchieri and
Karlin, 1998) with the capability of evaluating the level of
divergence in related proteins and highlight conserved se-
quence blocks to identify potential functional domains
within the vICA and vMIA homologues. When the vMIA
homologues were aligned, six similarity blocks were iden-
tified (Fig. 1C), three toward the amino termini (amino acids
1–40 relative to vMIA) and three toward the carboxyl
termini (amino acids 103–141 relative to vMIA). Sequences
that composed the central portion of vMIA, known to be
dispensable for its antiapoptotic function (Hayajneh et al.,
2001a), were highly divergent or absent in some viruses.
Remarkably, both pAgm37x1 and pRh37x1 contained large
deletions that juxtaposed similarity blocks 1–3 and 4–6,
which suggested that the central portion of vMIA may be
dispensable for function during natural infection. Consistent
with this suggestion, pCh37x1 exhibited a high level of
similarity in conserved regions that overlapped with func-
tional domains of vMIA (77% identity in similarity blocks
2, 3, and 6 and no gaps) while the central portion retained
very little similarity. Although other primate CMV
pUL37x1 homologues were more divergent (approximately
55% similarity), the known vMIA functional domains were
largely conserved. Domain A of pRh37x1 contains an ad-
ditional proline that breaks the region into two conserved
blocks (Fig 1C). Altogether, we conclude that the domains
known to be both necessary and sufficient for cell death
suppression by vMIA, aa 5–34 and 118–147 (Hayajneh et
al., 2001a), overlap with highly conserved regions (similar-
ity blocks 2–3 and 6) in all viruses that have a recognizable
vMIA homologue.
vICA homologues
An alignment of six CMV and herpesvirus tupaia vICA
homologues yielded 16 blocks of sequence similarity (Fig.
1D). The most conserved blocks (with the percentages of
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similarity indicated in parentheses) in the six viruses where
we had complete sequence data were block 7 (39%), block
8 (46%), block 10 (48%), block 11 (46%), block 12 (53%),
block 13 (23%), and block 16 (39%). The sequence infor-
mation available for pAgm36 truncated the predicted pro-
tein at Ile346 (block 11), such that the blocks 12–16, though
likely to be present based on other homologues, were not
included. Block 2 was conserved in both rodent and primate
CMVs, but not in herpesvirus tupaia, and block 5 was
conserved in herpesvirus tupaia and primate CMVs, but not
in rodent CMVs. Two mutant UL36 derivatives have been
reported: (1) a spontaneous deletion and rearrangement of
sequences between Leu156 and His295 of TownevarRIT3
pUL36 that removes blocks 4 through 8 and (2) a single
amino acid mutation of Cys131 in block 2 to Arg131 in
AD169varATCC (Skaletskaya et al., 2001). This Cys is
conserved in every primate CMV but is replaced by a
conservative substitution in rodent CMV homologues. Ad-
ditional similarity blocks were found only in rodent or
primate CMV homologues, and one of these (block 1, with
98% similarity) was very highly conserved. Block 15 was
not present in either human or ChCMV, and blocks 3, 4, 6,
9, and 14 appeared to be conserved in all primate CMVs.
The conserved vICA domains may be involved in cell death
suppression if these homologues are functional.
HCMV vICA homologues are members of the US22
family, which contain an established set of motifs (I to IV)
(Chee et al., 1990; Kouzarides et al., 1988) that are con-
served in all betaherpesviruses, including HHV6A,
HHV6B, and HHV7 (Efstathiou et al., 1992; Gompels et al.,
1995; Nicholas, 1994, 1996). In contrast, pT36 of herpes-
virus tupaia retains only motif IV, found within similarity
block 8 (Fig. 1D). Our analysis extended this family to
include pRh36 and pAgm36, which like the other homo-
logues retained all four motifs (Fig. 1D). An alignment with
a broader set of 89 US22 family proteins from all betaher-
pesviruses (pfam02393, RPS-BLAST) revealed homology
beyond the US22 motifs spanning conserved blocks 2 to 8
(data not shown). Taken together, the motifs and blocks
conserved in vICA homologues suggested that some com-
mon US22 family member function might facilitate cell
death suppression but that the homologues could be distin-
guished from other family members. The mutations in
AD169varATCC and TownevarRIT3 alter the US22 do-
main (motifs III and IV, respectively), consistent with this
domain being important in function. Given that other US22
family members have not been found to suppress cell death
(Menard et al., 2003), conserved similarity blocks 1 and 9 to
16, which lie outside of US22 family motifs, may be in-
volved in function.
Functional analysis
We assayed the function of UL36 and UL37 homologues
from RhCMV and MCMV in comparison to vICA and
vMIA. Phylogenetic analysis showed these to range from
being similar (Rh36 and Rh37) to being highly divergent
(M36 and M37) (Figs. 1A–D) and represent similarity
branches so that the information would help predict the
activity of others. Homologues were tested for their ability
to suppress Fas-mediated apoptosis in transiently or stably
transfected HeLa cells, a cell line used previously to char-
acterize both vICA and vMIA activity (Goldmacher et al.,
1999; Skaletskaya et al., 2001) (Table 1). pRh36 and pM36
both functioned well in these assays, exhibiting vICA-like
protection. Based on conserved function, pRh36 and pM36
were denoted Rh-vICA and M-vICA, respectively. This
ability to function predicts that the closely related proteins,
pAgm36 and pR36, may also play roles in cell death sup-
pression and suggests that the homologues found in all
betaherpesviruses may act in a similar way.
The full-length functional pRh36 used in these studies
(Fig. 1D) was generated by site-directed mutagenesis of a
sequenced clone. Sequence analysis predicted that the se-
quenced variant would produce a truncated 245-amino-acid
(Lys245) polypeptide due to the frameshift mutation. When
both the full-length and truncated pRh36 were compared,
only the full-length form protected (Table 1) in a cell death
assay. Thus, the carboxyl terminus including US22 domain
motif IV was required to protect cells from apoptosis.
Table 1
Antiapoptotic activity of proteins encoded by the UL36 and UL37 homologues of RhCMV and MCMV
Gene transfected Transiently transfected HeLa cells Stably transfected HeLa colonies











pcDNA3 (vector) No 284 0 0.4
Rh-vICA (wild type) Yes (strong) Not done Not done Not done
Rh68-1-vICA (mutant) No 440 0 0.2
M-vICA Yes (strong) 60 40 67
vICA Yes (weak) Not done Not done Not done
Rh-vMIA Yes (strong) 488 27 5.5
M37 No 440 0 0.2
vMIA Yes (strong) 72 16 22
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The identification of a mutant pRh36 in a stock of the
68-1 strain was reminiscent of variants found in HCMV
stocks (Prichard et al., 2001; Skaletskaya et al., 2001). In
order to investigate the impact of this mutation on virus
infection and pathogenesis, we sequenced the gene from a
recombinant virus, RhCMV-EGFP, that replicated well in
both cultured fibroblasts and fetal macaques (Chang et al.,
2002). The nucleotide sequence of a PCR product spanning
the mutation confirmed the presence of the inactivating
thymidine insertion in this recombinant virus. To determine
whether virus retained this mutation after passage through a
host, the entire Rh36 ORF from viral DNA isolated from
brains of two infected fetuses (Chang et al., 2002) was
amplified by PCR and sequenced. This DNA retained the
mutation, indicating that expression of full-length pRh36
was not required for infection and pathogenesis in vivo in
fetal macaques.
The RhCMV pUL37x1 homologue protected HeLa cells
from Fas-mediated apoptosis, demonstrating that this ho-
mologue retained vMIA function. Based on this activity,
pRh37x1 was denoted Rh-vMIA. The retention of vMIA
domains A and B in Rh-vMIA (see Fig. 1C) was consistent
with previous mapping of vMIA functional domains (Haya-
jneh et al., 2001a). A 50-amino-acid region from the middle
of vMIA was not necessary for function of Rh-vMIA, con-
sistent with the previously established behavior of vMIA
mutants (Hayajneh et al., 2001a). The similarity of
pAgm37x1 to pRh37x1 as well as pCh37x1 to vMIA pre-
dicts that these vMIA homologues are likely to carry out
similar functions.
We found that pM37, with sequence similarity only to
UL37x3, did not protect HeLa cells from apoptosis.
Whereas HCMV gene products gpUL37 and gpUL37M in-
clude the UL37x3 region, protection in cell death assays has
been ascribed to the presence of amino-terminal UL37x1
sequences (Goldmacher et al., 1999). With the possible
caveat that HeLa cells are insensitive to pM37 function,
these data suggest that the rodent UL37 homologues are
encoded for some other reason, possibly related to those
suggested for HCMV UL37x3 (Hayajneh et al., 2001b).
Transcript analysis
We next evaluated mRNA expression patterns during
murine or RhCMV infection of permissive fibroblasts and
compared these patterns to those of HCMV (Kouzarides et
al., 1988; Tenney and Colberg-Poley, 1991). RNA blot
hybridization with an M36-specific single-stranded RNA
probe (M36-1; Fig. 2A) detected a 1.9-kb transcript by 8 h
postinfection (h.p.i) that persisted through late times. This
transcript was also detected by probes M36-2 (Fig. 2B) and
M36-3 (not shown) but not by M37-1 (Fig. 2C) or any of the
other probes shown in Fig. 2G (Figs. 2D–F and data not
shown). The 1.9-kb transcript was detected when infection
was carried out in the presence of the protein synthesis
inhibitor cycloheximide (CHX) or when viral DNA repli-
cation was inhibited with phosphonoacetic acid (PAA), in-
dicating that M36 was an  (immediate early) gene. The size
and kinetics of expression of this 1.9-kb M36 transcript
were similar to the principle UL36 transcript made by
HCMV (Kouzarides et al., 1988; Tenney and Colberg-
Poley, 1991). Probe M36-1 also detected a transcript of 1.1
kb that did not hybridize to M36-2, M36-3, or any of the
other probes shown in Fig. 2G (Figs. 2A–F and data not
shown). The 1.1-kb transcript was less abundant than the
1.9-kb transcript but showed similar kinetics and response
to protein and DNA synthesis inhibitors, suggesting that it
may encode a portion of M36. Transcripts initiating up-
stream of M38 and transcribing through M37 and M36,
which would be analogous to HCMV (Kouzarides et al.,
1988; Tenney and Colberg-Poley, 1991), were not detected
in MCMV, although a portion of M36 corresponding to
M36-2 (but not M36-1 or M36-3) may be contained on
larger transcripts 2.9, 4.4, 5.9, and 7.5 kb in size (Figs. 2A
and B and data not shown). These results highlight similar-
ities as well as differences in transcription from the UL36
colinear region of MCMV and HCMV (Fig. 2G).
Transcript analysis of the M37 region revealed differ-
ences from what has previously been presented for MCMV
(Lee et al., 2000; Menard et al. 2003) and differences from
the colinear region of HCMV (Kouzarides et al., 1988;
Tenney and Colberg-Poley, 1991). Hybridization with an
M37-specific single-stranded RNA probe detected tran-
scripts 1.0, 2.1, 3.5, 4.4, and 4.9 kb in size by 8 h.p.i and
through late times (Fig. 2C). Levels of the 4.9-kb transcript
increased dramatically between 8 and 24 h.p.i. and were
blocked when viral DNA replication was inhibited with
PAA. This transcript was not detected when infection was
carried out in the presence of the protein synthesis inhibitor
CHX, indicating that this was a  (late) gene. The remaining
transcripts through this region were all  kinetic class. We
used additional RNA probes to dissect expression through
this region (Figs. 2D–G and data not shown). The 1.0- and
2.1-kb transcripts hybridized only with M37-specific
Fig. 2. Expression of transcripts of the UL36 and UL37 gene homologues in permissive cells infected by MCMV. RNA samples isolated from uninfected
(Un)NIH/3T3 cells or those infected with MCMV at a multiplicity of 5 PFU/cell in the presence or the absence of CHX, 50 g/ml, or PAA, 250g/ml, were
separated by gel electrophoresis and the blots were hybridized to probe M36-1 (A), probe M36-2 (B), probe M37-1 (C), probe M38-2 (D), probe m39-1(E),
or probe m40-1 (F). (G) Schematic representation of the M36–M40 (nucleotides 47,621 to 53,630) region ORFs (open rectangles) within the M36–M40
segment (nucleotides 47,621–53,630) in the MCMV Smith strain genome (Rawlinson et al., 1996). The locations of antisense probes for transcript analysis
are shown as arrowheads below the ORFs. Black arrows at the bottom depict the positions of transcripts predicted to encode M-vICA and pM37 from this
analysis. Gray arrows depict the hybridization patterns of predicted transcripts including all or a portion of M36 or M37 in addition to other ORFs in the
region.
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probes, while the larger transcripts hybridized to probes
surrounding M37 (Figs. 2C–F and data not shown). Based
on the size of M37 and the position of a proximal predicted
polyadenylation site, the 1.0-kb transcript most likely en-
coded pM37. The remaining transcripts could not be unam-
bigously mapped. The 3.5-kb transcript most likely encoded
pM38 based on hybridization only to probes M37-1 (Fig.
2C), M38-1 (data not shown), and M38-2 (Fig. 2D), but the
length of the transcript predicts an initiation site within m39.
The 4.4-kb transcript most likely encoded m39 based on
hybridization to M37-1 through M39-1 (Figs. 2C–E and
data not shown), but the length of transcript predicts an
initiation site upstream of m40. Based on size and kinetics,
the 4.4-kb transcript that hybridized to M36-2 and M37-1
through M39-1 may be the same. Finally, hybridization to
M37-1 through M40-1 suggested the major late 4.9-kb tran-
script encoded m40 or an ORF upstream of m40 (Figs. 2C–F
and data not shown). Fig. 2G depicts a summary of tran-
script mapping data for M36 and M37.
The 3.5-kb transcript shown in Figs. 2C and D likely
initiates upsteam of M38, suggesting that this transcript may
encode a 196-codon, non-annotated ORF (m38.5) overlap-
ping with the amino terminus of M38 (Fig. 2G). This ORF,
mapping to nucleotides 52367–51780, showed similarity to
the amino-terminal region of vMIA. The most extensive
region of identity (33% over 27 residues) aligned with the
vMIA mitochondria localization domain (domain A in Fig.
1C and data not shown). m38.5 is also conserved in RCMV
(data not shown). Initial attempts to protect HeLa cells from
apoptosis with m38.5 failed (data not shown). Although this
is consistent with limited homology to the vMIA carboxy1-
terminal antiapoptotic domain, it will be appropriate to
evaluate m38.5 in mouse cells or in animals.
An RNA blot analysis of cells infected with RhCMV was
performed with a single-stranded antisense Rh36 probe that
detected a single viral transcript of 2.1 kb (Fig. 3A). The
transcript was present as early as 4 h.p.i., and its expression
was suppressed in cells restricted to the initial phase of
infection by treatment with CHX. To confirm the integrity
of the viral transcripts collected in the presence of CHX, the
membranes were probed to show the presence of ie1 (not
shown), an abundant  gene product. Similar results were
obtained following infection in the presence of high (180
g/ml) (Fig. 3A) or low (50 g/ml) (not shown) concen-
trations of CHX. This gene exhibited  (delayed early)
kinetics of expression such that transcripts were present
even when viral DNA replication was inhibited with gan-
ciclovir. The physical map distance suggests that this tran-
script initiates distal to Rh36. Thus, the transcription of
Rh36 differed from that of HCMV vICA in three ways:
Rh36 was encoded by transcripts of a single length, initia-
tion was at a site distal to Rh36 but the transcript apparently
did not include Rh37x1 (Fig. 3B), and Rh36 accumulated
with  (delayed early) kinetics.
The RNA blot analysis of RhCMV-infected cells de-
tected Rh37x1 region transcripts of 1.4 and 0.8 kb (Fig. 3B),
both of which were expressed as early as 4 h.p.i. and were
detected in cells infected in the presence of inhibitors of
DNA replication but were not detected in cells infected in
the presence of CHX. Like Rh36, the Rh37x1 homologue
exhibited  (delayed early) gene kinetics of expression. The
physical map distance between Rh37x1 and the polyadenyl-
ation signal immediately downstream of Rh38 was appro-
priate to encode a 1.4-kb transcript, suggesting a situation
similar to that with HCMV. Thus, our data indicate that
M36 and M37 transcripts were similar in kinetics but dif-
ferent in arrangement than those of HCMV, whereas Rh36
and Rh37x1 transcripts exhibited different kinetics but sim-
ilar arrangement than HCMV (Kouzarides et al., 1988;
Tenney and Colberg-Poley, 1991).
Discussion
Studies of HCMV vICA and vMIA have revealed activ-
ities analogous to FLIPs and Bcl-2/E1B19k family mem-
bers, respectively, although these viral proteins lack se-
quence similarity to these families (Goldmacher, 2002;
Goldmacher et al., 1999; Skaletskaya et al., 2001). All
betaherpesviruses analyzed to date encode a vICA homo-
logue. We have shown that the pM36 of MCMV, with only
19% similarity to pUL36, nevertheless functions as a strong
suppressor of extrinsic induction of cell death. Thus, other
more closely related vICA homologues also likely retain
this activity. vICA is dispensable for HCMV (Patterson and
Shenk, 1999; Skaletskaya et al., 2001), RhCMV (Chang et
al., 2002), and MCMV (Menard, et al. 2003) replication in
fibroblasts. We have shown that each of these proteins is
sufficient for protection from extrinsic induction of apopto-
sis, which is a characteristic that would be expected to be
Fig. 3. Expression of transcripts of the UL36 and UL37 gene homologues
in permissive cells infected by RhCMV. RNA samples isolated from
uninfected (Un) rhesus macaque fibroblasts or fibroblasts infected with
RhCMV at a multiplicity of 1 PFU/cell in the presence or the absence of
CHX at 180 g/ml or GCV at 100 g/ml and separated by gel electro-
phoresis prior to hybridization with an antisense probe to RhUL36 (A) or
RhUL37 (B) mRNA.
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important in the context of viral infection in the intact host
where virus faces innate and adaptive immune responses.
It now appears that the strain of RhCMV employed for
animal studies carried a frameshifted pRh36 (Chang et al.,
2002; Chang and Barry, 2003) discovered through sequence
analysis reported here. This virus, or a BAC-cloned deriv-
ative, retained the ability to replicate in fetal macaques
following intracranial inoculation and persisted for up to 27
weeks after intravenous inoculation in more mature, juve-
nile animals. These results question whether Rh-vICA plays
any role in the natural host. A direct comparison of Rh-
vICA mutant and wild-type virus will be necessary to de-
termine whether the expression of Rh-vICA makes a differ-
ence in levels of growth reflecting modulation of immune
clearance or extrinsic apoptosis. A role of pRh36 in protec-
tion from apoptosis may emerge following these studies as
was described for MCMV. A report appearing after submis-
sion of this paper suggests that growth of MCMV in cul-
tured macrophages is dependent on M36 to reduce
caspase-8 activity during infection (Menard et al. 2003).
vICA activity likely requires sequences unique to UL36
homologues and sequences common to the US22 family.
Our results suggest that domains required for protection
from apoptosis likely map to conserved regions in rodent
and primate vICAs (see Fig. 1D), which include US22
family motifs I–IV contained in conserved blocks 2, 7, and
8 as well as conserved blocks 10–13 and 16 outside of any
US22 similarity. Our analyses revealed that mutations pre-
viously shown to disrupt vICA also disrupt US22 family-
common regions. The single amino acid inactivating muta-
tion (Cys131 to Arg131) in the US22 family motif III of
AD169varATCC pUL36 is an example of such a disruption.
An inactivating deletion/rearrangement in TownevarRIT3
pUL36 impacts US22 motif IV and is consistent with a role
for this region as well. Conserved blocks 10–13 and 16
outside of the US22 family motifs are also likely to be
involved in cell death suppression given that suppression of
apoptosis is not a common property of US22 family mem-
bers (Menard et al. 2003).
Our analysis of UL37x1 homologues indicates conserva-
tion overlapping with vMIA functional domains. Despite
having deleted a large portion of sequence relative to vMIA
and having retained only 33% similarity, Rh-vMIA was
fully protective. This result suggests that other similarly
divergent homologues may be functional. The two vMIA
domains necessary and sufficient for cell death suppression
(Hayajneh et al., 2001a) essentially correspond to conserved
domains 2, 3, and 6 and constitute the majority of sequence
common to all homologues. Other domains, such as the
acidic domain of pUL37x1 (amino acids 81–108) impli-
cated in early gene promoter activation (Colberg-Poley et
al., 1998), did not overlap with conserved sequences.
The roles of vMIA and vICA during infection of a host
with the respective CMV are likely to differ. Our work
demonstrates that RhCMV encodes vICA as well as vMIA,
whereas MCMV encodes a single function. vMIA appears
to be more important to HCMV than vICA since mutations
render the virus dependent on inhibitors of apoptosis in
cultured fibroblasts (G. Hahn, personal communication, Ab-
stract 7.06, 2001 International Herpesvirus Workshop, Re-
gensberg). While this role of vMIA is limited to primate
CMVs, all betaherpesviruses carry a larger UL37 gene com-
prised of the carboxyl-terminal (exon 3) portion of HCMV
gpUL37. This nonessential region seems more broadly con-
served in primate and rodent betaherpesviruses and may be
involved in transcriptional regulation (Hayajneh et al.,
2001b) rather than in cell death suppression (Goldmacher et
al., 1999).
Global transcription in the region was evaluated and the
results suggested striking differences from previous studies
of HCMV and MCMV (Kouzarides et al., 1988; Tenney and
Colberg-Poley, 1991; Lee et al., 2000; Menard et al. 2003).
Previous studies on MCMV (Lee et al., 2000; Menard et al.
2003) presented only a subset of the transcripts shown in
Fig. 2B and reported two different sizes (4.0 and 1.7 kb,
respectively, for the two studies) for the M37-specific tran-
script that we determined to be 1.0 kb. This means that both
studies may have assigned a phenotype based on incomplete
transcriptional analysis. Direct evaluation of viral insertion
or deletion mutants provides critical information on gene
function, but only when the impact on all transcripts through
a region is evaluated. The discrepancies in size and number
of M36 and M37 transcripts reported may reflect method-
ological or viral strain differences which will need to be
addressed. We employed strand-specific probes and RNA
from different times and infection conditions to more thor-
oughly dissect transcript patterns, but our results may be
influenced by viral strain differences. Notwithstanding these
differences, the apparent 1-kb size of the M37 transcript
matches the distance between the M37 AUG and the most
proximal polyadenylation signal in either of the two MCMV
strains currently used, although RNA splicing or internal
initiation may certainly occur. The 1.7-kb transcript re-
ported by Menard et al. (2003) may represent the 2.1-kb
transcript we mapped or may arise from the opposite DNA
strand. The 4.9-kb species in our studies likely represents a
previously reported 4.0-kb transcript (Lee et al., 2000)
based on abundance and the probes employed. The 4.9-kb
species appeared to initiate at a site 5 proximal to the m40
ORF and was not M37-specific in our work and represents
either a 2 or 1 gene. Other less abundant transcripts in this
region appear to be  genes.
MCMV exhibits similar kinetics for M36 and M37 tran-
scripts but different arrangement compared to HCMV. The
1.0-kb M37-specific transcript is predicted to terminate at a
polyadenylation site downstream of the M37 ORF (Rawlin-
son et al., 1996). It should be noted that no polyadenylation
site analogous to this can be found in the HCMV genome
where transcripts terminate immediately downstream of
UL36 or UL38 (Kouzarides et al., 1988; Tenney and Col-
berg-Poley, 1991).
Our observation that transcription of Rh36 and Rh37
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exhibited kinetics of  genes was unexpected. In contrast to
the kinetics observed with HCMV or MCMV, the expres-
sion of RhCMV homologues is dependent on the initial set
of regulatory gene products. Whether timing of expression
provides an advantage to virus-infected cells remains to be
addressed with viral mutants. Experimentally, cells infected
with HCMV vICA mutants do not become resistant to
apoptosis until 48 h.p.i., consistent with vMIA localization
to mitochondria (Goldmacher et al., 1999). Despite their
being  genes, it appears that Rh-vICA and Rh-vMIA ex-
pression patterns may still satisfy this pattern.
The conservation and functional importance of antiapop-
totic proteins such as vMIA provides a rationale for devel-
oping new antiviral drugs that inhibit the function of these
proteins to restore apoptotic pathways in infected cells. Our
finding that RhCMV encodes a functional cell death sup-
pressor very similar by its structure to vMIA suggests that
this virus may possibly serve as an appropriate in vivo




Plasmid pCla20 containing a 12.5-kbp RhCMV strain
68-1 (ATCC VR-677) DNA fragment was derived by clon-
ing of ClaI-digested viral DNA isolated from infected pri-
mary rhesus fibroblasts into the pGEM7Zf() vector. The
underrepresentation of CpG dinucleotides in combination
with more extensive methylation in cellular DNA lead to an
enrichment in clones containing RhCMV DNA.
Expression plasmids encoding human vMIA (UL37x1myc/
pcDNA3) and vICA (UL36AD169varDEmyc/pcDNA3) have
been described previously (Goldmacher et al., 1999; Ska-
letskaya et al., 2001). Fragments of MCMV Smith strain
DNA (Rawlinson et al., 1996) spanning the entire coding
region of M36 or M37 were generated by PCR and cloned
into pcDNA3myc. The resulting plasmids, M36/
pcDNA3myc and M37/pcDNA3myc, allow expression of
either amino-terminal myc epitope-tagged pM36 or pM37,
respectively. Similarly, the segments of genomic DNA
spanning the predicted coding region of either Rh36 (a
mutant denoted Rh3668-1 encoding a functionally inactive
protein) or Rh37 were generated by PCR with primers
5CCCAAGCTTCCACCATGCCTGCCATCCCTAT3 and
5CCGGAATTCTAATCTTCACTGCGCTTCAG3 using
pCla20 as the template and cloned into pcDNA3myc to
make the vectors Rh3668-1/pcDNA3myc and Rh37/
pcDNA3myc for the expression of these proteins. A wild-
type Rh36 (denoted Rh36) clone was constructed in
pcDNA3myc by removing a T at nucleotide 2831 of plas-
mid Rh3668-1/pcDNA3myc by site-directed mutagenesis.
The fidelity of all clones was confirmed by DNA sequenc-
ing.
RNA analysis
NIH3T3 fibroblasts were infected with MCMV strain
(K181 strain) (Stoddart et al., 1994) or the lacZ-tagged
derivative RM427 (Saederup et al., 1999) at 5 plaque-
forming units (PFU)/cell and cultured in the presence or the
absence of CHX at 50 g/ml or PAA at 250 g/ml. Primary
rhesus macaque dermal fibroblasts were infected with Rh-
CMV strain 68-1 at 1 PFU/cell and cultured either with or
without CHX at 180 or 50 g/ml as indicated or ganciclovir
(GCV) at 100 g/ml. For infections performed in the pres-
ence of an inhibitor of either protein synthesis or viral DNA
replication, cells were incubated with drug-containing me-
dia for 2 h prior to infection through the time of RNA
harvest. RNeasy reagents (Qiagen) were used to isolate total
RNA as recommended by the manufacturer. For RNA blot
analysis, 10–20 g of each sample was separated by elec-
trophoresis through 1% agarose gels containing formalde-
hyde, transferred to BrightStar-Plus nylon membrane, and
hybridized to single-stranded RNA probes in accordance
with the manufacturer’s recommendations (Ambion, Inc.,
Austin, Texas). Viral gene-specific RNA probes were gen-
erated by in vitro transcription in the presence of [32P]CTP
using linearized plasmids or PCR-generated templates.
Rh36/pcDNA3myc and Rh37/pcDNA3myc were linearized
with HindIII to generate templates for rhesus CMV-specific
probes. A series of M36 through m40 probes were generated
(Fig. 2G). M36/pcDNA3myc was linearized with NaeI for
generation of M36-1. M37/pcDNA3myc was linearized
with SmaI for generation of M37-1. To generate template
for probes M36-2 and M36-3, viral DNA derived from
supernatant of fibroblasts infected with MCMV strain
K181 (Stoddart et al., 1994) was digested with SmaI and
fragments close to the predicted length (2.6 kb) for the M36
region were gel purified. Similarly, template for probes
M38-I through m40 was derived by digestion of viral DNA
with SnaBI and gel purification of fragments close to the
predicted length (4.8 kb) for the M37–m40 region. These
gel-purified restriction fragments were used in PCR reac-
tions to prepare DNA fragments including phage-derived
promoter sequences adjacent to viral gene-specific se-
quence. M36 DNA fragments were amplified by PCR with
primers 5TTAACCCTCACTAAAGGGTTCGGCCGGC-
TGCGTGGAC3 and 5TAATACGACTCACTATAGGGC-
GATGTTGCCGACCATCTGG3 (M36-2) or 5TTAACC-
CTCACTAAAGGGATGTATGAGCAAGAGGAAC3 and
5TAATACGACTCACTATAGGGGCCGAAGAGCATCA-
CGAACC3 (M36-3) from gel-purified SmaI fragments for
M36-2 and M36-3. M38, m39, and m40 DNA fragments
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ACGTTC3 and 5TAATACGACTCACTATAGGGATG-
CTGTGTACTCAGTTTTTGGGG3 (M39-1), or 5TTA-
ACCCTCACTAAAGGGCCGACTCTCTTCCCTCAACC3
and 5TAATACGACTCACTATAGGGATGTCGGGCAG-
AGGCGGAGG3 (M40-1) from gel-purified SnaBI fragments
for M38-1 through M40-1. Each of these primers included
phage-specific promoter (T7, TAATACGACTCACTAT-
AGGG, or T3, TTAACCCTCACTAAAGGG) and gene-spe-
cific sequences.
The sizes of viral transcripts were determined by com-
parison of their electrophoretic mobilities to those of 28S
and 18S ribosomal RNAs as well as mRNAs for -actin and
glyceraldehyde-3-phosphate dehydrogenase. Probes for cel-
lular mRNAs were made according to manufacturer’s spec-
ifications (Ambion). Transcript sizes were compared with
the physical map distance between the AUG of annotated
ORFs and proximal polyadenylation signals. Fig. 2G de-
picts predicted transcripts as black or gray arrows. The
black arrows correspond to predicted transcripts for which
observed length and hybridization patterns correlated to
possible initiation near to the AUG and termination at the
polyadenylation signal proximal to the ORF as well as
transcripts predicted to be shorter as a result of potential
internal initiation or splicing. The gray arrows correspond to
predicted transcripts which did not fit these criteria and are
shown relative to observed hybridization patterns.
Cell death/apoptosis assays
Two methods were used to detect antiapoptotic activity
of vMIA or vICA homologues. (1) HeLa transient transfec-
tion apoptosis assays have been described previously (Gold-
macher et al., 1999). Briefly, cells transiently transfected
with a test gene or an empty expression vector plasmid were
exposed overnight to anti-Fas antibody (7C11, Coulter) at
0.2 g/ml plus CHX at 10 g/ml and the degree of cell
death was determined by examining cell cultures under a
phase-contrast microscope. (2) To examine antiapoptotic
activity of a gene in stably transfected HeLa cells, cells were
transfected with the gene or an empty expression vector
plasmid and then cultured in the presence of geneticin (1
mg/ml), and the resulting pools of geneticin-resistant colo-
nies were examined for survival following overnight expo-
sure to anti-Fas antibody plus CHX as above.
Sequence analysis
GenBank accessible sequence included ChCMV,
MCMV, RCMV, herpesvirus tupaia, HHV6A and HHV7,
and AgmCMV (Accession Nos. AF480884, NC_004065,
NC_002512, NC_002794, NC_001664, NC_001716,
U27649, and AF065657). The primary nucleotide sequence
of RhCMV included in plasmid pCla20 containing a 12.5-
kbp RhCMV strain 68-1 DNA fragment was determined for
this study. In addition, segments spanning Rh36 or Rh37
ORFs were amplified by PCR using pCla20 DNA as tem-
plate. The PCR products were then cloned into expression
vectors and sequenced to confirm that the PCR product
retained sequence identical to that of the original plasmid.
To sequence Rh36 from RhCMV-EGFP (Chang et al.,
2002), a short DNA segment around the mutation, was PCR
amplified using the plaque-purified virus as template and
oligonucleotides 5CTGTGCGTCTCCTATCGTGTCTGTG3
and 5AACGGTTACCGCGTCTACGATATTAGG3 as
primers. To examine whether Rh36 retained the truncated
ORF or acquired a reverse mutation restoring a full ORF
after RhCMV-EGFP replication in vivo, the entire ORF was
amplified using DNA isolated from brain of two fetuses that
had been infected with RhCMV-EGFP (Chang et al., 2002)
as a template and oligonucleotides 5AGTTCAGTGAACT-
CAACGTG3 and 5CAGCTAAGCGATAGATGGAG3 as
primers. The PCR products were then combined and se-
quenced by a single pass in both directions using the prim-
ers 5AGTTCAGTGAACTCAACGTG3 and 5CAGCTA-
AGCGATAGATGGAG3.
Coding regions and splicing sites of sequence homo-
logues, Rh-vMIA and Rh-vICA, Agm-vMIA, and Agm-
vICA within the respective genomic sequences were pre-
dicted with the help of the BCM Gene Finder FGENES 1.5
program (http://dot.imgen.bcm.tmc.edu:9331/gene-finder/
gf.html). Homologues of RhCMV UL36 and UL37x1 were
identified between nucleotides 3645 and 2828 (denoted Rh-
vICA) and 6100 and 5815 (denoted Rh-vMIA) of plasmid
pCla20 (Accession No. AY158022). DNA sequences from
AgmCMV homologous to UL36 and UL37x1 were identi-
fied in GenBank tblastn searches using the BLAST program
from the Genetics Computer Group package using se-
quences resembling vICA or vMIA that were found in
the DNA segments U27649 (clone 3B628) and AF065657,
as well as additional clones from the Agm36 and Agm37
region, included U276876, AF065729, AF065774,
AF065780, and AF065695. Pairwise alignments of amino
acid sequences made using ClustalW1.8 (http://clustal-
w.genome.ad.jp/) were used to generate dendrograms. The
percentages given are the ClustalW score expressed as a
percentage for the two sequences within brackets or as a
range including the lowest and highest ClustalW scores
between any two sequences included within brackets. Mul-
tiple alignments were generated by the ITERALIGN algo-
rithm (http://giotto.stanford.edu/luciano/iteralign.html)
with default parameters (the similarity noted required sim-
ilarity in three consecutive amino acid residues and was
restricted to those regions including the majority of se-
quences in the alignment) and the results processed by
BOXSHADE 3.21 (http://www.ch.embnet.org/software/
BOX_form.html) restricting that shading of similar and
identical amino acids include positions for which similarity
was noted in at least 70% of the sequences in the align-
ment. Conserved regions are separated by a dash from
surrounding sequence in Figs. 1C and D. The US22
family protein conserved sequence was identified through
RPS-BLAST (http://www.ncbi.nlm.nih.gov/Structure/cdd/
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wrpsb.cgi). ORFs m38.5 and r38.5 were identified by trans-
lation of genomic sequences by the Gene Construction Kit
and similarities to vMIA and each other determined by SIM
and PRSS (http://searchlauncher.bcm.tmc.edu/seq-search/
alignment.html). Publication of the complete RhCMV ge-
nome appeared after submission of this paper and the ORFs
encoding Rh-vICA and Rh-vMIA have been denoted as
Rh61-60 and Rh66 and 62, respectively (Hansen et al.,
2003).
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